Annual Drug Patent Expirations for RAYALDEE
Rayaldee is a drug marketed by Eirgen and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.
This drug has one hundred and five patent family members in thirty-two countries.
The generic ingredient in RAYALDEE is calcifediol. One supplier is listed for this compound. Additional details are available on the calcifediol profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
